What is the clinical significance of slightly low protein on electrophoresis with Immunofixation (IFIX) in a patient presenting with foot drop?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Significance of Slightly Low Protein on Electrophoresis with IFIX in Foot Drop

A slightly low total protein on serum protein electrophoresis with immunofixation (IFIX) in a patient with foot drop has minimal clinical significance and does not explain the neuropathy; the critical finding to look for is an abnormal monoclonal protein (M-protein), which occurs in approximately 9% of polyneuropathy patients and can cause peripheral neuropathy through various mechanisms including POEMS syndrome, amyloidosis, or cryoglobulinemia. 1

Understanding the Test Results

The key distinction here is between total protein levels versus protein pattern abnormalities:

  • Slightly low total protein on electrophoresis is generally not clinically significant for neuropathy evaluation and may reflect nutritional status, liver function, or dilutional effects 1
  • What matters for neuropathy workup is the presence of a monoclonal spike or abnormal immunoglobulin pattern detected by immunofixation, not the total protein concentration 1, 2

Diagnostic Yield of SPEP/IFIX in Polyneuropathy

Serum protein immunofixation electrophoresis is one of the highest-yield screening tests for polyneuropathy, with abnormalities found in approximately 9% of patients with distal symmetric polyneuropathy 1. This makes it the second-highest yield test after blood glucose (11% abnormal) and higher than vitamin B12 (3.6% abnormal) 1.

Both serum and urine immunofixation should be performed because this combined approach is more sensitive than either test alone for detecting monoclonal proteins, and some patients produce only small amounts that may be missed on serum testing alone 2, 3.

What You're Actually Looking For

The clinically significant findings on SPEP/IFIX that explain neuropathy include:

  • Monoclonal gammopathy (M-spike on electrophoresis with specific immunoglobulin type on IFIX) 1, 2
  • IgM monoclonal protein with anti-MAG antibodies causing demyelinating neuropathy 3
  • Light chain only disease (may require urine IFIX to detect) 2
  • Hypogammaglobulinemia (low immunoglobulins, not just low total protein) in certain contexts 1

Comprehensive Workup for Foot Drop with Neuropathy

Since your patient has foot drop, the evaluation must determine the anatomical level of injury and underlying cause:

Immediate Localization Studies

  • Electrodiagnostic studies (EMG/NCS) to differentiate between common peroneal neuropathy at the fibular head (most common), L5 radiculopathy, lumbar plexopathy, or sciatic neuropathy 3, 4
  • MRI of lumbosacral spine if radiculopathy suspected based on EMG findings 1, 3
  • MRI of brain with parasagittal cuts if upper motor neuron signs present or EMG shows no peripheral lesion, as cortical lesions can rarely cause isolated foot drop 5, 6

Essential Laboratory Screening

The following tests have the highest diagnostic yield and should be completed 1, 3:

  • Fasting glucose and HbA1c (11% yield - diabetes is the most common cause) 1, 7, 3
  • Serum protein electrophoresis with immunofixation (9% yield - already done) 1
  • Vitamin B12 with methylmalonic acid and homocysteine (3.6-8% yield, especially if B12 is 200-500 pg/dL) 1, 3
  • TSH (thyroid dysfunction) 3
  • Complete blood count and comprehensive metabolic panel (renal function, liver function) 1
  • ESR or CRP (inflammatory/vasculitic causes) 1

Additional Testing Based on Clinical Context

  • Anti-MAG antibodies if demyelinating pattern on EMG with IgM monoclonal protein 3
  • Vasculitis panel (ANA, ANCA, anti-Ro/La) if systemic symptoms present 1, 3
  • HIV, hepatitis B/C if risk factors present 1, 3
  • Lumbar puncture with CSF protein if demyelinating neuropathy suspected (elevated in most cases) 1

Critical Pitfalls to Avoid

  • Do not dismiss the neuropathy workup based on a slightly low total protein - this finding is not the relevant abnormality 1, 2
  • Do not assume peripheral nerve injury without EMG/NCS confirmation, as central causes (cortical infarction, parasagittal lesions) can present with isolated foot drop 5, 6
  • Do not stop at serum IFIX alone - order urine protein electrophoresis with immunofixation as well, since light chain disease may be missed on serum testing 2, 3
  • Do not overlook diabetes screening even if the patient has no known history, as it accounts for 11% of polyneuropathy cases 1, 3

When to Pursue Further Hematologic Evaluation

If IFIX shows a monoclonal protein (not just low total protein), the patient requires:

  • Hematology consultation 2
  • Quantification of M-protein 2
  • Serum free light chain assay 2
  • 24-hour urine for total protein and urine immunofixation 2, 3
  • Skeletal survey or whole-body low-dose CT 2
  • Bone marrow biopsy if multiple myeloma or related disorder suspected 2

The slightly low total protein alone does not warrant these additional studies unless there is an abnormal protein pattern on immunofixation 1, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Immunofixation Electrophoresis in Clinical Practice

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Laboratory Workup for Peripheral Neuropathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Foot drop: where, why and what to do?

Practical neurology, 2008

Research

Foot drop: the first sign of an intracranial tumor?

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2007

Research

Cerebral infarction producing sudden isolated foot drop.

Journal of clinical neurology (Seoul, Korea), 2007

Guideline

Mast Cell Activation Syndrome Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.